Deoxyribonucleic Acid (DNA) Manufacturing Global Market Report 2026
상품코드:1951692
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
데옥시리보핵산(DNA) 제조 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 55억 8,000만 달러에서 2026년에는 65억 1,000만 달러로, CAGR 16.7%로 성장할 것으로 예상됩니다. 지난 수년간의 성장에는 고품질 플라스미드 및 합성 DNA에 대한 접근성 제한, 전통적인 화학적 DNA 합성법에 대한 의존도, 세포 및 유전자 치료 분야의 연구개발 확대, 학술 및 산업 연구 이니셔티브의 증가, 올리고뉴클레오티드 기반 의약품에 대한 수요 증가 등이 주요 요인으로 꼽힙니다.
데옥시리보핵산(DNA) 제조 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 119억 5,000만 달러에 달하고, CAGR은 16.4%를 기록할 전망입니다. 예측 기간 동안 성장 요인으로는 효소 및 화학적 DNA 합성 기술의 발전, 유전자 치료 및 백신 파이프라인의 확장, GMP 등급 DNA 생산 채택 증가, 장쇄 및 복합 DNA 구조체에 대한 수요 증가, 자동화된 DNA 제조 플랫폼과 디지털 워크플로우의 통합 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 치료용 GMP 등급 DNA 수요 증가, 백신용 플라스미드 및 합성 DNA 생산 확대, 유전자 합성 및 코돈 최적화 서비스 도입 확대, PCR, siRNA 및 안티센스용 올리고뉴클레오티드 합성 확대, 세포 및 유전자 치료제 파이프라인의 DNA 생산 통합 등을 꼽을 수 있습니다.
유전자 치료에 대한 수요 증가는 향후 데옥시리보핵산(DNA) 제조 시장의 성장을 촉진할 것으로 예상됩니다. 유전자 치료는 질병의 치료나 예방을 위해 결함이 있는 유전자를 수정하거나 대체하는 기술을 말하며, 맞춤의료는 개인의 유전적, 생물학적 특성 및 생활습관 특성에 맞게 의료 시술을 조정하는 것을 의미합니다. 유전자 치료에 대한 수요 증가는 낭포성섬유증, 겸상 적혈구 빈혈, 특정 유전성 실명 등 유전성 질환의 유병률 증가에 따른 것입니다. 데옥시리보핵산(DNA) 제조는 환자의 결함 유전물질을 교정하거나 대체할 수 있는 치료용 유전자를 개발 및 전달하는데 필요한 고품질의 맞춤형 DNA 서열을 제공함으로써 유전자 치료를 지원하고 있습니다. 예를 들어, 미국 유전자 및 세포 치료학회(ASGCT)에 따르면, 2024년 1월 기준 2024년 4분기에 사전 등록된 유전자 치료 프로그램 수는 2024년 3분기에 비해 83% 증가하여 1년여 만에 가장 큰 폭의 성장세를 기록했습니다. 따라서 유전자 치료에 대한 수요 증가가 데옥시리보핵산(DNA) 제조 시장의 성장을 견인하고 있습니다.
DNA 제조 시장에서 활동하는 주요 기업들은 유전자 및 세포 치료 애플리케이션의 품질, 안전성, 확장성을 향상시키기 위해 GMP 등급 플라스미드 DNA 생산과 같은 혁신적인 방법을 개발하는 데 주력하고 있습니다. GMP 등급 플라스미드 DNA 생산은 바이오의약품 제품의 품질, 안전성, 일관성을 보장하는 규제 가이드라인인 GMP(Good Manufacturing Practice) 조건 하에서 플라스미드 DNA를 생산하는 것을 말합니다. 예를 들어, 2025년 4월에는 미국에 본사를 둔 위탁개발제조기관(CDMO)인 프로바이오제노믹스(Provo Genomics)가 호프웰에서 자체 분석 시험, 방법 개발, 프로젝트 관리를 포함한 GMP 플라스미드 DNA 제조 서비스를 개시했습니다. 이 서비스는 자체 프로세스 개발, 분석 시험, 방법론 개발, 프로젝트 관리 등의 고유한 특징을 가지고 있어 여러 공급업체를 필요로 하지 않고 개발 일정을 단축할 수 있습니다. 본 서비스는 오염 위험을 최소화하면서 85% 이상의 슈퍼코일형 플라스미드 DNA 함량이라는 고품질 출력을 보장합니다. 또한, 프로바이오에서는 4주 납기로 GMP 준수 플라스미드를 제공하고, 3개월 이내에 완전한 GMP 등급의 플라스미드를 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별, 국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Deoxyribonucleic acid (DNA) manufacturing refers to the process of artificially creating or replicating deoxyribonucleic acid (DNA) sequences using advanced biochemical techniques. This involves synthesizing specific nucleotide sequences or amplifying existing DNA strands to produce large quantities of genetic material with high accuracy and purity.
The main types of deoxyribonucleic acid (DNA) manufacturing are plasmid deoxyribonucleic acid (DNA), synthetic deoxyribonucleic acid (DNA), gene synthesis, and oligonucleotide synthesis. Plasmid deoxyribonucleic acid (DNA) refers to a small, circular, double-stranded DNA molecule that exists independently of the chromosomal DNA within a cell. The multiple grades involved include good manufacturing practices (GMP) grade and research and development grade through various distribution applications such as cell and gene therapy, vaccines, oligonucleotide-based drugs, and others and cater to several end users such as pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations.
Tariffs have impacted the DNA manufacturing market by increasing the cost of imported enzymes, nucleotides, reagents, and specialized synthesis equipment. Segments like plasmid DNA, synthetic DNA, and oligonucleotide synthesis are particularly affected, with Asia-Pacific regions including China and India being major exporters of raw materials and instruments. This has led to higher production costs and potential delays in supply. On the positive side, tariffs have encouraged local manufacturing, investment in domestic production facilities, and innovation in cost-effective DNA synthesis technologies.
The deoxyribonucleic acid (dna) manufacturing market research report is one of a series of new reports from The Business Research Company that provides deoxyribonucleic acid (dna) manufacturing market statistics, including deoxyribonucleic acid (dna) manufacturing industry global market size, regional shares, competitors with a deoxyribonucleic acid (dna) manufacturing market share, detailed deoxyribonucleic acid (dna) manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the deoxyribonucleic acid (dna) manufacturing industry. This deoxyribonucleic acid (dna) manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The deoxyribonucleic acid (dna) manufacturing market size has grown rapidly in recent years. It will grow from $5.58 billion in 2025 to $6.51 billion in 2026 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to limited access to high-quality plasmid and synthetic dna, reliance on traditional chemical dna synthesis methods, growing r&d in cell and gene therapies, rising academic and industrial research initiatives, increasing demand for oligonucleotide-based drugs.
The deoxyribonucleic acid (dna) manufacturing market size is expected to see rapid growth in the next few years. It will grow to $11.95 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to advancements in enzymatic and chemical dna synthesis technologies, expansion of gene therapy and vaccine pipelines, increasing adoption of gmp-grade dna production, rising demand for long and complex dna constructs, integration of automated dna manufacturing platforms and digital workflows. Major trends in the forecast period include rising demand for gmp-grade dna for therapeutic applications, growth in plasmid and synthetic dna production for vaccines, increasing adoption of gene synthesis and codon optimization services, expansion of oligonucleotide synthesis for pcr, sirna, and antisense applications, integration of dna manufacturing in cell and gene therapy pipelines.
Increasing demand for gene therapies is expected to propel the growth of the deoxyribonucleic acid (DNA) manufacturing market going forward. Gene therapies refer to techniques that modify or replace faulty genes to treat or prevent diseases, while personalized medicine refers to tailoring medical treatment to an individual's genetic, biological, and lifestyle characteristics. The increasing demand for gene therapies is driven by the rising prevalence of genetic disorders such as cystic fibrosis, sickle cell anemia, and certain types of inherited blindness. Deoxyribonucleic acid (DNA) manufacturing supports gene therapies by providing the high-quality, custom DNA sequences necessary to develop and deliver therapeutic genes that can correct or replace faulty genetic material in patients. For instance, in January 2024, according to the American Society of Gene & Cell Therapy, a US-based organization, in fourth quarter of 2024, the number of pre-registration gene therapy programs experienced its largest increase in over a year, rising 83% compared to third quarter of 2024. Therefore, the increasing demand for gene therapies is driving the growth of the deoxyribonucleic acid (DNA) manufacturing market.
Major companies operating in the DNA manufacturing market are focusing on developing innovative approaches, such as GMP-grade plasmid DNA production, to enhance the quality, safety, and scalability of gene and cell therapy applications. GMP-grade plasmid DNA production refers to the manufacture of plasmid DNA under Good Manufacturing Practice (GMP) conditions, which are regulatory guidelines ensuring the quality, safety, and consistency of biopharmaceutical products. For instance, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), launched GMP Plasmid DNA Manufacturing Services in Hopewell with in-house analytical testing, method development, and project management. It offers unique features, including in-house process development, analytical testing, method development, and project management, eliminating the need for multiple suppliers and speeding up development timelines. The service ensures high-quality output with >=85% supercoiled plasmid DNA content while minimizing contamination risks. ProBio also offers GMP-like plasmids with a four-week delivery timeline and full GMP-grade plasmids within three months.
In February 2025, Maravai LifeSciences Holdings, Inc., a U.S.-based life sciences company, acquired Officinae Bio S.r.l. for an undisclosed amount. With this acquisition, Maravai aims to integrate Officinae's AI-enabled mRNA and DNA sequence design platform into its TriLink nucleic acid production business, accelerating the development of next-generation nucleic acid therapies. Officinae Bio S.r.l. is an Italy based biotech company specializing in AI-driven digital platforms for the biological design of DNA and RNA therapeutics.
Major companies operating in the deoxyribonucleic acid (dna) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.
North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the deoxyribonucleic acid (dna) manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The deoxyribonucleic acid (DNA) manufacturing market consists of sales of synthetic DNA, plasmid DNA, linear DNA, oligonucleotides, and gene constructs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Deoxyribonucleic Acid (DNA) Manufacturing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses deoxyribonucleic acid (dna) manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for deoxyribonucleic acid (dna) manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deoxyribonucleic acid (dna) manufacturing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
2) By Grade: Good Manufacturing Practices (GMP) Grade; Research And Development Grade
3) By Application: Cell And Gene Therapy; Vaccines; Oligonucleotide-Based Drugs; Other Applications
4) By End-Use: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations
Subsegments:
1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA; Non-GMP-Grade Plasmid DNA; High Copy Number Plasmids; Low Copy Number Plasmids; Bacterial Fermentation-Based Plasmid Production; Transfection-Grade Plasmid DNA
2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis; Chemical DNA Synthesis; Long DNA Fragments; Short DNA Fragments; Single-Stranded Synthetic DNA; Double-Stranded Synthetic DNA
3) By Gene Synthesis: Custom Gene Synthesis; Standard Gene Synthesis; Complex Gene Constructs; Codon Optimization Services; Gene Library Synthesis
4) By Oligonucleotide Synthesis: DNA Oligonucleotides; Modified Oligonucleotides; Long Oligonucleotides; PCR Primers; SiRNA And Antisense Oligos; Adapter And Linker Oligos
Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Lonza Group AG; Kaneka Corporation; Catalent Inc.; Charles River Laboratories International Inc.; WuXi Biologics Inc.; AGC Biologics Inc.; Integrated DNA Technologies Inc.; GenScript Biotech Corporation; Takara Bio USA Inc.; Twist Bioscience Corp.; Ajinomoto Bio-Pharma Services; OriGene Technologies Inc.; DNA Script SAS; Eurofins Genomics LLC; Touchlight Genetics Ltd.; Elegen Inc.; VGXI Inc.; PlasmidFactory GmbH & Co. KG.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Demand For Gmp-Grade Dna For Therapeutic Applications
4.2.2 Growth In Plasmid And Synthetic Dna Production For Vaccines
4.2.3 Increasing Adoption Of Gene Synthesis And Codon Optimization Services
4.2.4 Expansion Of Oligonucleotide Synthesis For Pcr, Sirna, And Antisense Applications
4.2.5 Integration Of Dna Manufacturing In Cell And Gene Therapy Pipelines
5. Deoxyribonucleic Acid (DNA) Manufacturing Market Analysis Of End Use Industries
5.1 Pharmaceutical Companies
5.2 Biotechnology Companies
5.3 Academic And Research Institutes
5.4 Contract Research Organizations (Cros)
5.5 Cell And Gene Therapy Developers
6. Deoxyribonucleic Acid (DNA) Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Deoxyribonucleic Acid (DNA) Manufacturing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Deoxyribonucleic Acid (DNA) Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Deoxyribonucleic Acid (DNA) Manufacturing Market Size, Comparisons And Growth Rate Analysis
7.3. Global Deoxyribonucleic Acid (DNA) Manufacturing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Deoxyribonucleic Acid (DNA) Manufacturing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Deoxyribonucleic Acid (DNA) Manufacturing Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Deoxyribonucleic Acid (DNA) Manufacturing Market
12.1. China Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Deoxyribonucleic Acid (DNA) Manufacturing Market
13.1. India Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Deoxyribonucleic Acid (DNA) Manufacturing Market
14.1. Japan Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Deoxyribonucleic Acid (DNA) Manufacturing Market
15.1. Australia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Deoxyribonucleic Acid (DNA) Manufacturing Market
16.1. Indonesia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Deoxyribonucleic Acid (DNA) Manufacturing Market
17.1. South Korea Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Deoxyribonucleic Acid (DNA) Manufacturing Market
19.1. South East Asia Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Deoxyribonucleic Acid (DNA) Manufacturing Market
20.1. Western Europe Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Deoxyribonucleic Acid (DNA) Manufacturing Market
21.1. UK Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22.1. Germany Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Deoxyribonucleic Acid (DNA) Manufacturing Market
23.1. France Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25.1. Spain Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Deoxyribonucleic Acid (DNA) Manufacturing Market
26.1. Eastern Europe Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Deoxyribonucleic Acid (DNA) Manufacturing Market
27.1. Russia Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Deoxyribonucleic Acid (DNA) Manufacturing Market
28.1. North America Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Deoxyribonucleic Acid (DNA) Manufacturing Market
29.1. USA Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Deoxyribonucleic Acid (DNA) Manufacturing Market
31.1. South America Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Deoxyribonucleic Acid (DNA) Manufacturing Market
32.1. Brazil Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Deoxyribonucleic Acid (DNA) Manufacturing Market
33.1. Middle East Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Deoxyribonucleic Acid (DNA) Manufacturing Market
34.1. Africa Deoxyribonucleic Acid (DNA) Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Deoxyribonucleic Acid (DNA) Manufacturing Market, Segmentation By Type, Segmentation By Grade, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Deoxyribonucleic Acid (DNA) Manufacturing Market Regulatory and Investment Landscape
36. Deoxyribonucleic Acid (DNA) Manufacturing Market Competitive Landscape And Company Profiles
